| | ADD (Attention Deficit Disorder) and ADHD (Attention Deficit Hyperactivity Disorder)
Featured Links
| ADD ADHD
Learn more about ADD and ADHD in children, teens and adults. Resources discuss ADD/ADHD symptoms, causes and treatment options.
http://www.thehealthcenter.info/
|
Standard ListingsSort by: PageRank | Hits | Alphabetical | Premature Babies Much More Likely To Have ADHD
Danish researchers have found that premature babies are 70% more likely to become children with ADHD if they are born at 34-36 weeks. The likelihood of having ADHD triples if the baby was born before 34 weeks. The study, which looked at 30,000 children,
http://www.medicalnewstoday.com/healthnews.php?newsid=44574&nfid=crss
|
| ADHD Skin Patch Approved By FDA
The FDA has approved the Daytrana patch, a skin patch for the treatment of ADHD (Attention Deficit Hyperactivity Disorder) in children. Regulators said the patch would help in the administration of ADHD drugs to children who find it hard to take pills or
http://www.medicalnewstoday.com/healthnews.php?newsid=41254&nfid=crss
|
| Advisers Reject "Black Box" Warning For ADHD Drugs
A Food and Drug Administration Pediatric Advisory Committee has rejected having "black box" warnings regarding psychiatric and cardiovascular risks associated with ADHD drugs. This advice goes against a recommendation issued one month ago by the Drug Saf
http://www.medicalnewstoday.com/healthnews.php?newsid=40166&nfid=crss
|
| ADHD Drugs Should Have Black Box Warning, Says FDA Advisory Panel
According to the FDA advisory panel, ADHD drugs, including Ritalin, Concerta, Methylin and Metadate should have a 'black box' warning. The FDA usually does what the advisory panel recommends. This is after data revealed that ADHD drugs may have caused 25
http://www.medicalnewstoday.com/healthnews.php?newsid=37584&nfid=crss
|
| New Study: Pine Bark Extract Reduces ADHD Symptoms In Children
A new study to be published in the June 17 edition of the journal of European Child and Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol - (pic-
http://www.medicalnewstoday.com/medicalnews.php?newsid=45434&nfid=crss
|
| New River Pharmaceuticals To Present Results From NRP104 Abuse Liability Studies
New RiverPharmaceuticals Inc. (Nasdaq: NRPH) announced today that it anticipatesthat results will be presented from its three clinical abuse liabilitystudies on NRP104, a compound being developed as a treatment forattention-deficit/hyperactivity disorder
http://www.medicalnewstoday.com/medicalnews.php?newsid=45193&nfid=crss
|
| Boys With ADHD Calm Down With Dance Therapy
Dance therapy can be a successful method for reaching children and adolescents with problems. This has been shown in a research project at Karlstad University and the University College of Dance in Stockholm, Sweden. Hyperactive and unruly boys with ADHD
http://www.medicalnewstoday.com/medicalnews.php?newsid=44846&nfid=crss
|
| New Book Explores Causes Of ADHD
Theories about what causes attention deficit hyperactivity disorder, or ADHD, are many and varied, with experts speculating on a wide range of probable causes - genetics, environmental pollutants, food allergies and challenging home environments. In his n
http://www.medicalnewstoday.com/medicalnews.php?newsid=44489&nfid=crss
|
| DAYTRANA (methylphenidate Transdermal System) Significant Reduces ADHD Symptoms
Philadelphia, US - Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that its methylphenidate transdermal system (MTS), DAYTRANA TM demonstrated statistically significant reductions in the symptoms of Attention Deficit Hyperactivity Disorder (ADHD)
http://www.medicalnewstoday.com/medicalnews.php?newsid=43981&nfid=crss
|
| Calming An "ADHD" Mouse
The paradoxical therapeutic actions of psychostimulant drugs in people with attention deficit and hyperactivity disorder (ADHD) are still mysterious. This week, Tanaka et al. shed some light on this question in mice lacking Adcyap1, the gene that encodes
http://www.medicalnewstoday.com/medicalnews.php?newsid=43158&nfid=crss
|
| Dacogen(TM) Approved For Patients With All FAB Classifications Of MDS
MGI PHARMA, INC.(Nasdaq: MOGN) and SuperGen, Inc. (Nasdaq: SUPG) todayannounced that the U.S. Food and Drug Administration (FDA) has approvedDacogen(TM) (decitabine) for Injection. [click link for full article]
http://www.medicalnewstoday.com/medicalnews.php?newsid=42738&nfid=crss
|
| Transdermal Patch Approved For Treatment Of ADHD
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that the U.S. Food and Drug Administration (FDA) approved DAYTRANA (methylphenidate transdermal system), the first and only non-oral medication for the treatment of attention deficit hyperactiv
http://www.medicalnewstoday.com/medicalnews.php?newsid=41333&nfid=crss
|
| Hyperactivity, Sleepiness, And ADHD Often Improved After Tonsillectomy
In fact, about half of the children in the study who were found to have Attention-Deficit/Hyperactivity Disorder before tonsil surgery no longer met criteria for this diagnosis one year later. Other cognitive and behavioral issues also improved.On the who
http://www.medicalnewstoday.com/medicalnews.php?newsid=40958&nfid=crss
|
| Study Examines Risk For Misuse Of ADHD Stimulant Medications
A major concern regarding the use of stimulant medications to treat attention-deficit hyperactivity disorder (ADHD) in adolescents and young adults has been the risk that they will be misused or diverted to those for whom they have not been prescribed. [c
http://www.medicalnewstoday.com/medicalnews.php?newsid=40713&nfid=crss
|
| Recent Trends In Children's Stimulant Prescriptions For ADHD, USA
The percentage of U.S. children taking stimulants for attention deficit hyperactivity disorder (ADHD) remained at a constant level between 1997 and 2002. These data were collected by the federal government and are summarized in an article in the April 200
http://www.medicalnewstoday.com/medicalnews.php?newsid=40778&nfid=crss
|
| |
